Polymyxin resistant clinical isolates from LMIC
Collection and characterization of clinical isolates from Low/Medium Income Countries (LMIC), selected for multi- and extreme-drug resistance  (MDR/XDR) against current antibiotics, especially against Polymyxin B and Colistin